CD47 Targeting Therapeutics Market Analysis and Immuno-Oncology...

σε πρόσθεσε στο Health

2026-01-05 12:04:30 -

CD47 Targeting Therapeutics Market Analysis and Immuno-Oncology Landscape

The CD47 Targeting Therapeutics Market analysis highlights the growing significance of CD47 as a promising target in cancer immunotherapy. CD47, often referred to as the “don’t eat me” signal, is overexpressed in many cancer cells, allowing them to evade immune system clearance. Therapeutics targeting CD47 aim to block this signal, enabling macrophages to recognize and...

0 Σχόλια 0 Μοιράστηκε 375 Views 0 Προεπισκόπηση